Partnership / Collaboration · GCC · Announced 3 Sept 2026
Pharmacare Premium → Arabian Oasis
Partnership / Collaboration deal between Pharmacare Premium (Malta) and Arabian Oasis (Saudi Arabia), announced 3 Sept 2026. Value: Undisclosed.
Parties: PHARMACARE PREMIUM LTD (Malta) → ARABIAN OASIS (Saudi Arabia)
- Deal type
- Partnership / Collaboration
- Value
- Undisclosed
- Territory
- Saudi Arabia
- Therapeutic area
- Oncology
- Asset
- A specialized oncology medicines portfolio (specific molecules not disclosed)
- Announced
- 3 Sept 2026
Our analysis
Executive summary.
Pharmacare Premium — a Malta-based, EU-GMP manufacturer specializing in high-potency ("contained production") finished products — and Arabian Oasis, a Saudi distribution house, signed a Memorandum of Understanding and Strategic Agreement to collaborate on the registration, supply, and progressive localization of oncology medicines in Saudi Arabia.
The full analysis is free to read with a work email on this page.
Source: Partnership announcement (LinkedIn, Arabian Oasis / Pharmacare Premium).